Status:

COMPLETED

Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer

Lead Sponsor:

University of Medicine and Dentistry of New Jersey

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Prostate Cancer

Eligibility:

MALE

18+ years

Phase:

PHASE1

Brief Summary

RATIONALE: Vitamin E supplements may stop or delay the development of prostate cancer in patients who are at risk of prostate cancer or who have prostate cancer. It is not yet known which vitamin E re...

Detailed Description

OBJECTIVES: * Determine the effect of tocopherol supplementation on plasma and urine levels of α-, γ-, and δ-tocopherols, PSA, and prostaglandin E\_2 by comparing the blood and urine samples collecte...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Meets one of the following criteria:
  • Abnormal digital rectal examination or abnormal prostate specific antigen (\> 4.0 ng/mL)
  • Obstructing prostate
  • Biopsy-proven prostate cancer
  • Scheduled to undergo prostate surgery (i.e., transurethral prostatectomy or prostatectomy)
  • PATIENT CHARACTERISTICS:
  • No uncontrolled diabetes, uncontrolled blood pressure, chronic congestive heart failure, or history of renal insufficiency
  • No personal or family history of a bleeding disorder
  • No known history of problems absorbing dietary fats (e.g., Crohn's disease, cystic fibrosis)
  • PRIOR CONCURRENT THERAPY:
  • More than 2 weeks since prior NSAIDs or corticosteroids
  • No concurrent supplementation of vitamin E (a multivitamin containing ≤ 60 IU of vitamin E is allowed)
  • No concurrent colestipol or orlistat
  • No concurrent warfarin or dicumarol

Exclusion

    Key Trial Info

    Start Date :

    April 1 2009

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    May 1 2012

    Estimated Enrollment :

    65 Patients enrolled

    Trial Details

    Trial ID

    NCT00895115

    Start Date

    April 1 2009

    End Date

    May 1 2012

    Last Update

    June 14 2012

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School

    New Brunswick, New Jersey, United States, 08903